Good news | "Suzhou Digital PCR Diagnostic Platform Engineering Technology Research Center" was awarded to ApBio

2024-04-13

According to the "Notice on the Release of the 2022 Suzhou Science and Technology Development Plan (First Batch) Project Guidelines and Organization of Application" (Su Ke Zi [2022] No. 5) and the "Notice on the Organization of Application for the 2022 Suzhou Science and Technology Innovation Carrier Plan Project", after evaluation, Apbai Bio was awarded the "Suzhou Digital PCR Diagnostic Platform Engineering Technology Research Center".

The Enterprise Engineering Technology Research Center aims to promote the enterprise's scientific and technological innovation, carry out a series of engineering technology research and experiments, develop common and key technologies in industrial development, continuously provide mature supporting technologies, processes and products, promote the transformation of results, and enhance the enterprise's technological innovation capabilities and market competitiveness.

ApBio's instrument development platform based on multiple fluorescence detection technology

Apbai Biotech (Suzhou) Co., Ltd. is a national high-tech enterprise and a leading talent enterprise in Suzhou. It has passed ISO13485 and ISO9001 quality system certification. It has obtained a number of national authorized patents and software copyrights related to nucleic acid trace detection and digital PCR detection, and has been approved for a number of product registration certificates and product filing certificates related to multiple PCR technology platforms. It has a solid foundation and rich experience in hardware and software such as molecular biology research and experimental technology. It has built instrument research and development platforms such as rapid PCR, rapid quantitative PCR, internationally leading digital PCR detection platform, and microscopic imaging acquisition and analysis; it has built a trace nucleic acid detection development platform, and continues to develop molecular diagnostic detection and clinical detection products such as disease-related molecular and cytogenetic testing, targeted drug guidance, etc. It has a technically strong R&D team and undertakes a number of provincial and ministerial technical R&D projects.